Re:Almost a third of our portfolio is under attack by patent...
by mseebach on Tuesday January 12, 2010 @06:09AM
(#1047274)
I don't know if that's correct, but if it is, it's patents that make it possible for the universities and NIH to sell the right exclusively.
Since manufacturing, testing and marketing a drug is hysterically expensive, the patent seems to serve a purpose there -- even if pharma companies are more akin to specialized investment bankers than scientists.
Re:Almost a third of our portfolio is under attack by patent...
by paraschopra on Tuesday January 12, 2010 @12:20PM
(#1047959)
Actually it will be unwise to generalize for all pharma companies but yes it is a standard practice to license rights from labs/univ
it's the NIH and universities (via government funding) that actually discover the drugs, then they sell the exclusive rights to manufacture it to big pharma (who then spends a lot to get it approved and market it and such...)
(this is the book, i haven't read it) http://www.amazon.com/Truth-About-Drug-Companies-Deceive/dp/...
so in this case (if true) patents fail again.